Topic

Vice President, Scientific eTech-Enabled Services, Calyx

Articles

Stakeholders from across the industry must discuss ownership to ensure effective implementation.

Clarifying Ownership of Clinical Trial IRT Data: Site vs. Sponsor

Whether it is increased outsourcing or insourcing, the FSP model has become a strategic choice, given its flexibility, scalability and the increased control of decision making to the sponsors.

Best Practices in Utilizing the FSP model: Clinical Operations, Pharmacovigilance, Regulatory and Other Areas

Marcus A. Banks is a freelance health journalist

Proactive, pervasive, and strategic planning lead industry into future.

Biopharma-Academic Collaborations in 2021

In this interview, Dave Hanaman, co-founder, president and chief commercial operator at Curavit Clinical Research discusses launching the organization at the start of the pandemic and how it operates with a commitment to designing trials with a fully virtual site.


Taking DCTs to the Next Level

Strong collaboration critical as trial development advances.

Building Relationships Key for Smaller Sponsors 

Technology, talent and specialization add up to a plethora of industry M&As.

The Post-Pandemic CRO Landscape

A move back to in-house management of clinops could be on the horizon for sponsors.

Could Technology Supplant CROs?

A brief look at the market for mergers and acquisitions since the year of COVID.

The Tangled Web of Large Outsourced Providers 

New BDO CRO Insights Report reveals high rate of CRA turnover and what organizations are doing to combat it.

Turnover for Clinical Monitoring Remains High

Steven Bukvic, CEO of the ACROSS Global Alliance, speaks to Applied Clinical Trials about how it works to improve the clinical trial experience for smaller- and medium-sized sponsors.

CRO/Sponsor